Research, Select, & Monitor Monday, January 21, 2019 4:37:39 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Bioverativ Inc.$104.98$.33.32%

  Quote | Ranking | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

 Bioverativ to Report Fourth Quarter and Year-End 2017 Financial Results on February 13, 2018
   Tuesday, January 16, 2018 4:15:00 PM ET

Bioverativ Inc. (BIVV ) today announced it will report fourth quarter and year-end 2017 financial results on Tuesday, February 13, 2018, after the market closes. The press release will be available in the "Investor Relations" section of the company’s website at

On Wednesday, February 14, 2018, at 8:00 a.m. EST, the company will host a live webcast with Bioverativ management. To access the live webcast, please visit Bioverativ’s Investors page at An archived version of the webcast will be available following the presentation.

About Bioverativ

Bioverativ (BIVV ) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 following separation from Biogen Inc., Bioverativ builds upon a strong heritage of scientific innovation and is committed to actively working with the blood disorders community. The company’s mission is to create progress for patients where they need it most and its hemophilia therapies when launched represented the first major advancements in hemophilia treatment in more than two decades. For more information, visit or follow @bioverativ on Twitter.

View source version on

SOURCE: Bioverativ Inc.

Bioverativ Inc. 
Sam Chase, +1 781-663-9277

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2019 All rights reserved.